Compare PNFP & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PNFP | ALGN |
|---|---|---|
| Founded | 2000 | 1997 |
| Country | United States | United States |
| Employees | 3595 | N/A |
| Industry | Major Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | 12.4B |
| IPO Year | N/A | 2000 |
| Metric | PNFP | ALGN |
|---|---|---|
| Price | $97.50 | $177.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 12 |
| Target Price | $113.31 | ★ $199.82 |
| AVG Volume (30 Days) | ★ 1.4M | 908.3K |
| Earning Date | 04-22-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.05% | N/A |
| EPS Growth | N/A | ★ 0.53 |
| EPS | N/A | ★ 5.65 |
| Revenue | N/A | ★ $387,126,000.00 |
| Revenue This Year | $160.52 | $5.78 |
| Revenue Next Year | $9.24 | $4.62 |
| P/E Ratio | ★ $12.24 | $31.53 |
| Revenue Growth | N/A | ★ 23.95 |
| 52 Week Low | $81.08 | $122.00 |
| 52 Week High | $120.39 | $208.31 |
| Indicator | PNFP | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 60.13 | 46.09 |
| Support Level | $92.97 | $175.35 |
| Resistance Level | $101.94 | $183.34 |
| Average True Range (ATR) | 2.59 | 6.44 |
| MACD | 0.40 | -0.83 |
| Stochastic Oscillator | 75.25 | 26.41 |
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.